Drug intelligence / Profile preview

4-(5,11-dioxo-5H-indeno[1,2-c]isoquinolin-6(11H)-yl)butanoate

Development stage
Unknown
Modality
Small Molecules
01

Overview

4-(5,11-dioxo-5H-indeno[1,2-c]isoquinolin-6(11H)-yl)butanoate is a synthetic small molecule belonging to the indenoisoquinoline class of compounds. Indenoisoquinolines are aromatic polycyclic molecules that have been investigated for their potential as topoisomerase I inhibitors and possible antineoplastic (anticancer) agents. This compound is considered experimental and has not been approved for clinical use. Its mechanism of action is presumed to involve inhibition of DNA topoisomerase I by stabilizing the cleavable complex between DNA and the enzyme during replication or transcription processes. The compound has primarily been studied in preclinical settings as a chemical probe or lead structure for further drug development within oncology research.[1][2][4]

Other names
4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE4-(5,11-dioxoindeno[1,2-c]isoquinolin-6-yl)butanoic acidindeno[1,2-c]isoquinoline-6-butyric acid
02

Targets

TOP1 (DNA Topoisomerase I)

Beyond the preview

Go deeper on 4-(5,11-dioxo-5H-indeno[1,2-c]isoquinolin-6(11H)-yl)butanoate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-(5,11-dioxo-5H-indeno[1,2-c]isoquinolin-6(11H)-yl)butanoate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call